WeightWatchers launches employer-subsidized GLP-1 medication program

NEW YORK - WW International, Inc. (NASDAQ:WW), currently trading at $29.23 and maintaining impressive gross profit margins of 70.7%, announced Friday the introduction of WeightWatchers RxFlexFund, a program that allows employers to subsidize GLP-1 weight loss medications for employees while providing behavioral and clinical support. According to InvestingPro analysis, the company appears undervalued based on its Fair Value assessment.

The new offering enables employers to cover between 25% and 75% of medication costs while gaining access to direct manufacturer pricing. The program includes care from obesity-trained clinicians, nutritional support designed for GLP-1 users, and access to dietitians and fitness specialists.

"Employers are at a crossroads when it comes to GLP-1 benefits," said Scott Honken, Chief Commercial Officer of WeightWatchers. "Our clients consistently tell us that costs are rising and traditional coverage models leave little flexibility or opportunity for innovation."

The company cited data indicating that annual healthcare expenses are reduced by 20% when individuals with at least one chronic condition lose weight and move from obesity to overweight. According to WeightWatchers’ 2025 Annual Results Report, participants in the WeightWatchers Clinic program reported a 46% boost in work-related quality of life. The company’s strong financial position is reflected in its healthy current ratio of 1.88, indicating solid ability to meet short-term obligations. InvestingPro data reveals 8 additional key financial insights available to subscribers.

Dr. Kim Boyd, Chief Medical Officer of WeightWatchers, stated that the program "reimagines the equation by introducing a new model to expand access to GLP-1 treatment to those who would benefit while maintaining medical responsibility and long-term behavior change support."

WeightWatchers RxFlexFund is being marketed as part of the company’s WeightWatchers for Business platform, which serves employers, health plans, and payers.

The announcement was made in a press release statement from the company, which describes itself as the global leader in science-backed weight management.

In other recent news, WW International, Inc., commonly known as WeightWatchers, has made several strategic announcements. The company launched a new program, WeightWatchers for Menopause, aimed at supporting women through various stages of menopause. Grammy and Emmy Award-winning actress Queen Latifah has been named as the program’s first official spokesperson, bringing her personal experience to the role. Additionally, WeightWatchers appointed Julie Rice, co-founder of SoulCycle and a longtime board member, as the Chief Experience Officer. Rice will focus on transforming the company’s global workshop business, which hosts 20,000 monthly meetings across 11 markets. She will also oversee the revitalization of WeightWatchers’ community approach to weight management and lead the brand team responsible for content and communications. These recent developments reflect WeightWatchers’ efforts to expand its programs and enhance customer engagement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.